Cultivation Capital’s Life Sciences Fund II invests in early-stage life sciences companies, primarily in the therapeutics, diagnostics, research tools and reagents, medical devices, and healthcare information technology verticals.

Our sweet spot is providing post-seed/pre-Series A stage companies the capital they need to rapidly scale their businesses. Our initial investment ranges from $250,000 – $1,000,000, with opportunities for follow-on investment.

Our partners are seasoned entrepreneurs turned investors, who know what it takes to grow and successfully exit a life sciences business. Drawing upon their expertise, we actively support our portfolio companies, many times serving as a lead investor and board member.


Bill Schmidt
Managing Partner


Rick Ryan
General Partner

Bobby Sandage Site

Bobby Sandage
General Partner


David Smoller
General Partner


NarrativeDx is the artificial intelligence (AI) platform for patient experience.